News, Articles & Resources
Cancer Research and Cancer Support Articles
Xofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone.
Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Marcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
Florida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
Dr. Hussein met with His Majesty King Abdullah II of Jordan to strengthen ties with Jordanian medical professionals working in the U.S.
Learn more about the causes, symptoms and treatment options for head and neck cancers of the mouth, throat, larynx, nose, sinuses or salivary glands.
Florida Cancer Specialists & Research Institute data leads to study on blood cancer being published in the Journal of Modern Economics.
Florida Cancer Specialists & Research Institute, a physician-owned practice, reinforces its commitment to physician leadership.
FCS Top News Updates
October 23, 2026
FCS Drug Development Research Featured at ESMO Congress 2026
October 20, 2026
FCS Leadership Review of Step Therapy Policies Details Troubling Impacts to Cancer Patients
October 19, 2026
FCS Welcomes Kelly Elleson, MD, FACS, Breast and Melanoma Surgical Oncologist
October 15, 2026
FCS Clinical Summit Advances Strategic Priorities, Research Innovation & Excellence in Patient Care
Xofigo® Treatment: What You Can ExpectXofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone.
Lutathera® Treatment: What You Can ExpectLutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
FCS Expands Specialized Gynecologic Oncology ServicesMarcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced CancersFlorida Cancer Specialists & Research Institute associate director Judy Wang, MD, is lead author of a manuscript on oral bacterial therapy to improve immunotherapy outcomes.
Maen Hussein, MD Meets With King Abdullah II Ahead of UN General Assembly to Strengthen U.S.–Jordan Medical TiesDr. Hussein met with His Majesty King Abdullah II of Jordan to strengthen ties with Jordanian medical professionals working in the U.S.
Head and Neck CancerLearn more about the causes, symptoms and treatment options for head and neck cancers of the mouth, throat, larynx, nose, sinuses or salivary glands.
FCS Utilizes Proprietary Real-World Data in First Study of Treatment Response in Lower-Risk Myelodysplastic Syndrome Patients Treated with Erythropoiesis-Stimulating AgentsFlorida Cancer Specialists & Research Institute data leads to study on blood cancer being published in the Journal of Modern Economics.
Physician-Owned Practice Reinforces Commitment to Physician LeadershipFlorida Cancer Specialists & Research Institute, a physician-owned practice, reinforces its commitment to physician leadership.